Search for Stocks /

Dr Agarwal’s Eye Hospital Ltd Q3 FY26 – ₹451 Cr Sales, 32% OPM, 29.5% ROE, and a Merger That Wants to Swallow Itself

Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.

1. At a Glance – Blink and You’ll Miss the Growth

₹2,260 crore market cap. Stock at ₹4,677. P/E of 32.4. ROE flirting with 30%. OPM chilling at ~32% like it owns the place. In Q3 FY26, revenue clocked ₹116 crore (+22% YoY) while PAT jumped 66% YoY to ₹17.3 crore. This is not a sleepy regional eye clinic anymore — this is a cataract cash machine with an MBA.

But wait, there’s drama. Promoters have pledged ~29% of their stake. Debt stands at ₹335 crore. And just when investors were getting comfortable tracking AEHL, management said: “Relax, we’re merging you into the parent.”

So what exactly is Dr Agarwal’s Eye Hospital Ltd? A clean compounding healthcare story? Or a well-lit operating theatre hiding balance-sheet sutures? Let’s scrub in.


2. Introduction – From Eye Camp to Eye Empire

Founded in 1994, Dr Agarwal’s Eye Hospital Ltd (AEHL) started with a simple idea: fix eyesight at scale in Tamil Nadu. Fast forward three decades, and the company operates 63 facilities, employs 200+ doctors, and serves ~5.9 lakh patients annually, performing ~62,000 surgeries in FY25 alone.

Cataract is the hero here — boring, repetitive, and insanely profitable. Like a Bollywood remake franchise, but for eyeballs. Add refractive surgeries, glaucoma, retina, LASIK, optics, diagnostics, and suddenly you have a vertically integrated ophthalmology assembly line.

AEHL is also a subsidiary of Dr Agarwal’s Health Care Ltd (DAHCL), which owns ~72%. And that’s important — because the parent is now planning to merge AEHL into itself, effectively ending AEHL’s solo listed life by FY27.

So before this stock becomes a memory, let’s understand whether it deserved the premium it enjoyed.


3. Business Model – WTF Do They Even Do?

Think of AEHL as a hub-and-spoke eye factory.

Step 1: Vision Centres

Small clinics, low capex, high footfall. These act as funnels. Patients come in for checkups, diagnostics, specs, consultations.

Step 2: Surgical Centres

Serious stuff happens here. Cataract surgeries, retina work, LASIK. This is where margins explode.

Step 3: Opticals + Pharmacy

Because why stop at surgery margins when you can also sell lenses, specs, and eye drops?

Read Full 16 Point breakdown. Continue reading →
EduInvesting runs entirely on reader support — ₹360 a year keeps the lights on.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →